Johnson & Johnson (JNJ) reported Q1 FY 2020 earnings of $2.30 per share (versus $2.10 per share in Q1 FY 2019), beating analysts' consensus estimate of $2.00 per share.

The company's quarterly revenues amounted to $20.691 bln (+3.3% y/y), beating analysts' consensus estimate of $19.476 bln.

The company also issued lowered guidance for FY 2020, projecting EPS of $7.50-7.90 (down from $8.95-9.15 previously) versus analysts' consensus estimate of $8.08 and revenues of $79.2-82.2 bln (down from $85.8-86.6 bln previously) versus analysts' consensus estimate of $79.54 bln.

JNJ rose to $144.00 (+3.03 %) in pre-market trading.